Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Mechanisms of isoniazid and rifampicin-induced liver injury and the effects of natural medicinal ingredients: A review
Xiuping Zhuang, Li Li, Tianyi Liu, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 40

Showing 1-25 of 40 citing articles:

Addressing the global challenge of bacterial drug resistance: insights, strategies, and future directions
Arun Karnwal, Amar Yasser Jassim, Ameer A. Mohammed, et al.
Frontiers in Microbiology (2025) Vol. 16
Open Access | Times Cited: 2
Drug-induced liver injury and anti-hepatotoxic effect of herbal compounds: a metabolic mechanism perspective
Jyoti Rani, Sanju Bala Dhull, Pawan Kumar Rose, et al.
Phytomedicine (2023) Vol. 122, pp. 155142-155142
Closed Access | Times Cited: 33
Hepatoprotective effects of natural drugs: Current trends, scope, relevance and future perspectives
Sonal Datta, Diwakar Aggarwal, Nirmala Sehrawat, et al.
Phytomedicine (2023) Vol. 121, pp. 155100-155100
Closed Access | Times Cited: 23
Chinese guideline for the diagnosis and treatment of drug-induced liver injury: an update
Yimin Mao, Shiwu Ma, Chenghai Liu, et al.
Hepatology International (2024) Vol. 18, Iss. 2, pp. 384-419
Closed Access | Times Cited: 12
Rifampicin-induced ER stress and excessive cytoplasmic vacuolization instigate hepatotoxicity via alternate programmed cell death paraptosis in vitro and in vivo
KM Kainat, Mohammad Imran Ansari, Nuzhat Bano, et al.
Life Sciences (2023) Vol. 333, pp. 122164-122164
Closed Access | Times Cited: 11
Anti-tuberculosis drug-induced liver injury
Wei Shen Lim, Anthony Avery, Onn Min Kon, et al.
BMJ (2023), pp. e074866-e074866
Closed Access | Times Cited: 11
Effect of adenosine triphosphate on methylphenidate-induced oxidative and inflammatory kidney damage in rats
Bahtınur Yeter, Zeynep Süleyman, Seval Bulut, et al.
Drug and Chemical Toxicology (2025), pp. 1-9
Closed Access
Prediction of tuberculosis treatment outcomes using biochemical makers with machine learning
Zheyue Wang, Zhenpeng Guo, Weijia Wang, et al.
BMC Infectious Diseases (2025) Vol. 25, Iss. 1
Open Access
High-Purity Frustrated Kagome Fe3Sn2Thin Films: Synthesis, Property Tuning, and Application in Rifampicin Degradation
Asma Romdhani, Moez Hajji, R. Ayed, et al.
Optical Materials (2025), pp. 116847-116847
Closed Access
Potensi hepatoprotektif ekstrak daun Euphorbia heterophylla L. dalam menurunkan kadar bilirubin pada tikus Wistar yang diinduksi INH dan rifampisin
Khamdiyah Indah Kurniasih, Fauziah Fauziah, Uki Septi Ratna
Journal of Pharmaceutical And Sciences (2025), pp. 412-419
Open Access
Cell-based approaches for the mechanistic understanding of drug-induced cholestatic liver injury
Enrique Timor-López, Laia Tolosa, M. Teresa Donato
Archives of Toxicology (2025)
Open Access
Bi and Bi-Ni Codoped CuO-ZnO Mixed Oxides: Advanced Catalysts for Efficient Rifampicin Degradation: Influence of Catalyst Dosage, pH, and Scavengers
Moez Hajji, Anis Akkari, Antonio J. García‐Loureiro, et al.
Chemistry Africa (2025)
Closed Access
Recent advances in the role of polysaccharides in liver diseases: a review
Junfeng Wang, Hanxiang Wang, Xiawen Yang, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Polysaccharides from Dicliptera chinensis (L.) Juss. Attenuates drug-induced liver injury by phosphorylating AMPK and thus facilitating the entry of FOXO3 into the cell nucleus
Chaoyue Yang, Mingli Zhong, Xuefei Jiao, et al.
International Immunopharmacology (2025) Vol. 155, pp. 114633-114633
Closed Access
A near‐infrared fluorescent probe for detecting hydrazine metabolized from isoniazid in living cells
Shude Pang, Baoshuai An, Zhuo Miao, et al.
Luminescence (2024) Vol. 39, Iss. 1
Closed Access | Times Cited: 2
Changing Trajectories of Alanine Aminotransferase and Risk of Antituberculosis Drug‐Induced Liver Injury in Chinese Patients: A Cohort Study
Xinyu Chen, Hongqiu Pan, Zhuolu Hao, et al.
The Journal of Clinical Pharmacology (2024) Vol. 64, Iss. 7, pp. 840-848
Closed Access | Times Cited: 2
Severe dengue infection unmasking drug‐induced liver injury: Successful management with N‐acetylcysteine
Naveen Gautam, Nishan Shrestha, Sanjeev Bhandari, et al.
Clinical Case Reports (2024) Vol. 12, Iss. 3
Open Access | Times Cited: 2
Preclinical liver toxicity models: advantages, limitations and recommendations
Devaraj Ezhilarasan, Sivanesan Karthikeyan, Mustapha Najimi, et al.
Toxicology (2024), pp. 154020-154020
Closed Access | Times Cited: 2
A novel perspective on the preventive treatment of hydrazine compound-induced liver injury: Isoniazid liver injury as an example
Xinyu Li, Chengxian Li, Chenyi Li, et al.
Journal of Ethnopharmacology (2023) Vol. 315, pp. 116616-116616
Open Access | Times Cited: 6
The Effect of Bergenin on Isonicotinic Acid Hydrazide and Rifampicin-Induced Liver Injury Revealed by RNA Sequencing
Ting Li, Chaoyue Yang, Houkang Cao, et al.
Molecules (2023) Vol. 28, Iss. 14, pp. 5496-5496
Open Access | Times Cited: 5
Lansoprazole Ameliorates Isoniazid-Induced Liver Injury
Eri Wakai, Takashi Shiromizu, Shota Otaki, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 1, pp. 82-82
Open Access | Times Cited: 1
Clinical risk factors for moderate and severe antituberculosis drug-induced liver injury
Quanxian Liu, Lu Huang, Hong Yan, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 1
Protective effects of thiamine pyrophosphate and cinnamon against oxidative liver damage induced by an isoniazid and rifampicin combination in rats.
Bahtınur Yeter, Renad Mammadov, Zeynep C. Koc, et al.
Investigación Clínica (2024) Vol. 65, Iss. 3, pp. 321-334
Open Access | Times Cited: 1
Screening of novel narrow-spectrum benzofuroxan derivatives for the treatment of multidrug-resistant tuberculosis through in silico, in vitro, and in vivo approaches
Débora L. Campos, Christian S. Carnero Canales, Fernanda Manaia Demarqui, et al.
Frontiers in Microbiology (2024) Vol. 15
Open Access | Times Cited: 1
Efficient analysis of drug interactions in liver injury: a retrospective study leveraging natural language processing and machine learning
Junlong Ma, Heng Chen, Ji Sun, et al.
BMC Medical Research Methodology (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top